BJDX BLUEJAY DIAGNOSTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, BLUEJAY DIAGNOSTICS INC reported revenue of n/a, net income of −$2.32M and diluted EPS of −$1.12; for the fiscal year ended December 2025 revenue was n/a.
BJDX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$6.95M, net income −$6.85M (margin n/a), EPS −$15.25
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$7.17M, net income −$7.72M (margin n/a), EPS −$456.75
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$10.3M, net income −$9.95M (margin n/a), EPS −$3631.48
- Fiscal year ended Dec 2022: revenue $249K, gross profit $48.9K, operating income −$9.32M, net income −$9.30M (margin -3733.1%), EPS −$9.22
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$3.23M, net income −$3.49M (margin n/a), EPS −$0.41
BJDX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$2.32M, EPS −$1.12
- Quarter ended Mar 31, 2026: revenue n/a, net income −$1.92M, EPS −$1.95
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$1.43M, EPS $4.86
- Quarter ended Sep 30, 2025: revenue n/a, net income −$1.60M, EPS −$1.01
- Quarter ended Jun 30, 2025: revenue n/a, net income −$1.96M, EPS −$5.64
- Quarter ended Mar 31, 2025: revenue n/a, net income −$1.86M, EPS −$13.46
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$1.43M, EPS $271.11
- Quarter ended Sep 30, 2024: revenue n/a, net income −$1.48M, EPS −$76.94
- Quarter ended Jun 30, 2024: revenue n/a, net income −$2.48M, EPS −$256.16
- Quarter ended Mar 31, 2024: revenue n/a, net income −$2.33M, EPS −$394.76
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$2.30M, EPS −$3590.32
- Quarter ended Sep 30, 2023: revenue n/a, net income −$2.30M, EPS −$16.67
- Quarter ended Jun 30, 2023: revenue n/a, net income −$2.81M, EPS −$22.00
- Quarter ended Mar 31, 2023: revenue n/a, net income −$2.54M, EPS −$2.49
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$2.39M, EPS −$4.18
- Quarter ended Sep 30, 2022: revenue n/a, net income −$2.96M, EPS −$2.94
- Quarter ended Jun 30, 2022: revenue $249K, net income −$1.94M, EPS −$2.00
- Quarter ended Mar 31, 2022: revenue n/a, net income −$2.01M, EPS −$0.10
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$2.74M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income −$1.19M, EPS −$0.11
BJDX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$6.05M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$7.82M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$8.31M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$7.74M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.37M, share buybacks n/a
BJDX balance sheet
- Jun 30, 2026: cash $9.60M, total assets $11.5M, total liabilities $2.12M, shareholders' equity $9.41M
- Mar 31, 2026: cash $3.68M, total assets $5.60M, total liabilities $1.42M, shareholders' equity $4.18M
- Dec 31, 2025: cash $5.16M, total assets $7.12M, total liabilities $1.14M, shareholders' equity $5.98M
- Sep 30, 2025: cash $3.08M, total assets $4.89M, total liabilities $1.20M, shareholders' equity $3.69M
- Jun 30, 2025: cash $4.44M, total assets $6.40M, total liabilities $1.11M, shareholders' equity $5.29M
- Mar 31, 2025: cash $3.12M, total assets $5.28M, total liabilities $1.41M, shareholders' equity $3.87M
- Dec 31, 2024: cash $4.30M, total assets $6.66M, total liabilities $928K, shareholders' equity $5.73M
- Sep 30, 2024: cash $5.76M, total assets $8.35M, total liabilities $1.19M, shareholders' equity $7.16M
Is BJDX profitable?
No. BLUEJAY DIAGNOSTICS INC lost $7.27M over the last four quarters.
What is BJDX's EPS?
Diluted earnings per share over the last four quarters were $0.78; −$1.12 in the latest quarter.